Press Releases
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
15 out of 18 complete responders, or 83%, demonstrated ongoing complete responses for at least 36 months without any additional treatment for RRP 5 complete responders have ongoing responses beyond 4 years Follow-up is ongoing; median duration of complete response has not yet been reached No new adverse safety events have been observed during long-term follow-up US FDA granted seven-year period of orphan drug market exclusivity to PAPZIMEOS GERMANTOWN, Md., May 30, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced updated long-term follow-up data from the pivotal study of PAPZIMEOS™ (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP)...
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
SEZ6 expression exceeds that of approved and emerging ADC targets in SCLC SEZ6 expression is positively correlated with DLL3 expression across neuroendocrine carcinomas, indicating potential for combination Findings support Whitehawk's development of SEZ6-directed ADC, HWK-206, with an IND submission expected mid-2026 MORRISTOWN, N.J., May 30, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced the presentation of a real world analysis supporting the therapeutic potential of targeting seizure related homolog protein 6 (SEZ6) with a next-generation ADC for the treatment of neuroendocrine tumors, including small cell lung cancer (SCLC)...
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
MILLBRAE, Calif., May 30, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced presentations on several of its lead programs at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, including updated data for its EIK1001 trial in non-small cell lung cancer (NSCLC) and its highly selective PARP1 inhibitor EIK1003...
Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1 expression levels and subtypes, highlighting its potential to set a new standard of care Pumitamig plus chemotherapy showed robust and consistent antitumor activity in first-line non-small cell lung cancer at both evaluated dose levels, with higher confirmed objective response rates at the lower dose of 63.6% in the non-squamous and 72.7% in the squamous subtypes Pumitamig is advancing through a comprehensive global Phase 3 development program in non-small cell lung cancer, including the actively enrolling pivotal Phase 3 part of the ROSETTA Lung-02 trial, along with two additional global Phase 3 trials MAINZ, Germany, and PRINCETON, USA, May 30, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, “BMS”) today announced interim Phase 2 data from the global Phase 2/3 ROSETTA Lung-02 clinical trial (NCT06712316) evaluating the investigational PD-L1xVEGF-A bispecific immunomodulator pumitamig (also known as BNT327 or BMS-986545) plus chemotherapy in patients with previously untreated advanced non-small cell lung cancer (“NSCLC”). The data showed encouraging anti-tumor activity, with high response rates observed in both non-squamous and squamous NSCLC and at each PD-L1 expression level (TPS ˂ 1%, TPS 1 – 49%, and TPS ≥ 50%)...
BW LPG Enters Into Agreement for Eight 90'cbm Panamax Newbuildings with Hyundai Heavy Industries
SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”), the world's leading owner and operator of LPG vessels, announces that it has signed a contract for the construction of eight 90'cbm Panamax Very Large Gas Carriers (VLGCs), for a total consideration of about US$940 million, subject to the final technical specifications. The newbuildings are expected to be delivered sequentially from the start of 2029 until the second quarter of 2030. “This newbuil...
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026.
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants with chronic kidney disease –
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX (cabozantinib) provided significant improvements in progression-free survival (PFS) versus placebo in patients with previously treated advanced neuroendocrine tumors (NET) regardless of functional status. These data will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held fr...
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek t...
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from the IGNYTE clinical trial of RP1 plus nivolumab in patients with anti-PD-1 failed melanoma during an oral session at the 2026 American Society of Clinical Oncology annual meeting...
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50, CI: 0.39-0.65, p
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer with a 63% objective response rate (ORR), 50% confirmed ORR (cORR), including four complete responses, and longest ongoing response at 12 months Additional Phase 1 data for IMA203CD8 in heavily pretreated patients with synovial sarcoma showed deep and durable responses with a 67% ORR and 64% cORR, including one complete response, and ongoing responses up to ~3 years IMA203CD8 demonstrated a manageable and consistent tolerability profile across patient populations Clinical anti-tumor activity observed across tumor types (ovarian carcinoma, uterine cancer, melanoma, synovial sarcoma) with distinct biology and differing levels of PRAME expression, including lower PRAME levels in ovarian carcinoma Clinical profile of IMA203CD8 supports continued development in gynecologic cancers and expansion into other PRAME-positive solid tumors Determination of recommended phase 2 dose (RP2D) remains expected in 2026 Houston, Texas and Tuebingen, Germany, May 30, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced updated Phase 1 data for its IMA203CD8 PRAME TCR T-cell therapy in gynecologic cancers and synovial sarcoma at the Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, USA...
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
No Reduction Observed in Combined Primary Endpoint of Stage III/IV Cancers in Aggregate; However, Decreases Observed Beyond the Prevalent Screening Round Annual Galleri Blood Test Reduced Stage IV Diagnoses of 12 Prespecified Cancers by 22% and 26% in the Second and Third Screening Rounds, Respectively Galleri Increased Cancer Detection Rate by Four-Fold When Added to Standard of Care Screening and Reduced Cancer Diagnosis Through Emergency Presentation by 25% Annual Testing With Galleri Increased Stage I-II Cancer Diagnoses by 16% When Added to Standard of Care GRAIL to Host Analyst Call From 2026 ASCO Annual Meeting MENLO PARK, Calif., May 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced detailed clinical utility, performance and safety results from its landmark NHS-Galleri trial in an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting1...
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will hold trial-in-progress poster presentations on the Phase 1/2a study of its lead targeted alpha radiotherapy candidate MP0712 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. ASCO takes place May 29-June 2 in Chicago, and SNMMI May 30-June 2 in Los Angeles...
Incyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte's frontMIND trial found Tafasitamab (Monjuvi/Minjuvi) combo significantly prolongs progression-free survival in high-risk DLBCL patients.
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in patients with progressing desmoid tumors. The data are being presented today in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual...
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #ASCO26--ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer.
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
NEW YORK--(BUSINESS WIRE)--TALAPRO-3 Data Presented at ASCO.
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit and Akeso, featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. The data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The presentation, entitle...
Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is or...
SMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative
NEW YORK CITY, NY / ACCESS Newswire / May 30, 2026 / Recycled plastic is no longer just a sustainability gesture. For years, it was treated as a responsible choice, a brand signal, or a way for companies to show progress toward environmental goals.
Number of shares and votes in BioArctic AB (publ) as of May 29, 2026
STOCKHOLM, May 30, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 5,000 Class B shares during May for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 5,000 stock options of series 2019/2028...
Replenish Nutrients: Market Has Yet to Price in the H2 2026 Capacity and Licensing Inflection
MALMÖ, Sweden, May 30, 2026 /PRNewswire/ -- Company:Replenish NutrientsListings: CSE Canada , Frankfurt and US OTC Tickers: ERTH / VVIVF / WIMNMarket cap at time of publication: $28 MCADStock price at time of publication: $0.14 CADBusiness: Regenerative agricultureWebsite:https://replenishnutrients.com/ ESGFIRE Commentary Replenish Nutrients has delivered its Q1 2026 results, and while the quarter itself reflects a deliberate transition, the single data point that matters most is already on the tape: a 29% gross profit margin on granulated fertilizer at the Beiseker facility — squarely inside the Company's previously communicated 25–35% range. The unit economics are proven...
FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million
MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the signing of a definitive agreement to acquire up to 102 Mission Pet Health (“MPH”) veterinary properties for a purchase price of up to $268.0 million from Shore Capital Real Estate Partners Fund I. Mission Pet Health is one...
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
NEW ORLEANS, May 29, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC0, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium longevity brand, announces a proposed non-brokered private placement financing (the "Private Placement"), consisting of the issuance of an aggregate of up to 2,500,000 units of the Company (each, a "Unit"), at a price of $1.00 per Unit for aggregate gross proceeds of up to $2,500,000. Each Unit will consist of one common share in the capital of the Company (each, a "Share") and one transferable common share purchase warrant of the Company (each, a "Warrant"), with each Warrant entitling the holder to acquire one additional Share (each, a "Warrant Share") at a price of $1.25 per Warrant Share for a period of 24 months from the date of closing...
Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings
VANCOUVER, BC, May 29, 2026 (GLOBE NEWSWIRE) -- Fobi” or the “Company”), a leader in AI powered data intelligence and digital wallet solutions, today provided an update regarding the status of the Company's ongoing efforts in connection with the revocation of the existing failure to file cease trade order (“FFCTO”) and the resumption of trading of the Company's common shares on the TSX Venture Exchange (the “TSXV”)...
Global Compliance Completes Acquisition of Global People's Trust
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Global Compliance Applications Corp. (CSE: APP) (FSE: 2FA) (OTCQB: FUAPF) ("GCAC" or the "Company") is pleased to announce that, further to the Company's news release dated March 9, 2026, that the Company has acquired (the "Acquisition") a 100% interest in Global People's Trust LP and Global People's Trust (Management) Limited (together, the "Global People's Trust") pursuant to a Share Purchase Agreement (the "Definitive Agreement") with Darrence Hugh Christian (the "Seller"). In accordance with the Definitive Agreement and as consideration for a 100% interest in Global People's Trust, the Company has issued the Seller 38,000,000 common shares in the capital of the Company (the "Consideration Shares") at a deemed price of $0.015 per Consideration Share...
The FUTR Corporation Reports Financial Results for Q1 2026
Three-Month Period Ended March 31, 2026 Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - The FUTR Corporation (TSXV: FTRC) (OTCQB: FTRCF) (FSE: QA20), creator of the FUTR Agent App which enables users to store, manage, access, and monetize their personal information and make intelligent payments (the "Company" or "FUTR"), today reported financial results for the three-month period ended March 31, 2026 (the "Quarter"). Period-over-period comparisons are made to the three-month period ended March 31, 2025...
Toogood Gold Signs Definitive Agreement for Option to Earn 100% Interest in the Table Mountain Project, Nevada
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Toogood Gold Corp. (TSXV: TGC) (OTCQB: TGGCF) (FSE: D3P) ("Toogood" or the "Company") today announced that it has entered into a definitive option agreement (the "Definitive Agreement") dated May 26, 2026 with Orogen Royalties Inc. and its subsidiary GenEx Exploration Inc. (collectively "Orogen"), and Altius Resources Inc. ("Altius"), and together with Orogen, the ("Vendors"), pursuant to which the Company has the exclusive right to earn a 100% interest in the Table Mountain Project (the "Project" or "Table Mountain"), located in Lincoln County, Nevada. Key Points Summary Definitive Agreement executed: Toogood has secured an exclusive option to earn a 100% interest in the Table Mountain Project in Nevada; Undrilled, district-scale low-sulphidation epithermal system: 4 x 2 km alteration footprint with multiple outcropping Au-Ag-bearing epithermal veins; Compelling first-pass geochemistry: Rock assays up to 2.6 g/t Au and >50 g/t Ag with strong Sb-As-Hg pathfinder anomalism, further supporting low-sulphidation epithermal affinity; No historical drilling: Large, well-preserved system remains effectively untested by modern exploration; Strategic location: 2-hour drive from Las Vegas and 10 km south of the Atlanta Gold Mine within the Indian Peak Caldera Complex; Aligned vendor structure: Equity-based earn-in with a 3.0% net smelter return ("NSR") royalty and staged buydown rights to 2.0%; Phase 1 exploration: Systematic property-wide campaign has commenced, including soil geochemistry (>6,150 samples), 1:5,000-scale structural and geological mapping, ground gravity, drone magnetics, prospecting, rock sampling and hand-held spectral analyses; Phase 2 exploration: Planned following Phase 1 and expected to include controlled-source audio-frequency magnetotellurics ("CSAMT") to map deeper resistive features, together with drill-target-focused mapping, prospecting and rock sampling; and Maiden drill program: Phase 1 exploration designed to deliver ranked drill targets and a permit-ready drill plan in Q3 2026...
CLPS Incorporation Receives Nasdaq Notification Regarding Minimum Bid Price Requirements
HONG KONG, May 29, 2026 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS) today announced that it received a notification letter (the "Notification Letter") from Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated May 27, 2026, indicating that the Company's closing bid price for its common shares fell below $1.00 per share for 30 consecutive trading days, which is not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. The Nasdaq notification does not affect CLPS's current listing or trading of the Company's securities on the Nasdaq Global Market...
Canadian Goldfields Appoints Harp Gosal as Director of Capital Markets and Communications
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Canadian Goldfields Discovery Corp. (TSXV: CGM) (OTCQB: CGMXF) ("Canadian Goldfields" or the "Company") is pleased to announce the appointment of Harp Gosal as Director of Capital Markets and Communications. The appointment reflects the Company's continued focus on strengthening its market engagement and communications platform as Canadian Goldfields advances its strategic objectives...
Core Critical Approved for Listing on OTCQB(R) Venture Market
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Core Critical Metals Corp. ("CCMC" or the "Company") (TSXV:CCMC)(OTCQB:CCMCF) (WKN: A41G8G), a North American mineral acquisition and exploration company, is pleased to announce that its common shares have been approved for listing on the OTCQB Venture Market, operated by OTC Markets Group Inc. The Company's shares now trade on the OTCQB under the ticker symbol "CCMCF". In addition, the Company is pleased to confirm that its common shares have achieved Depository Trust Company ("DTC") eligibility, greatly facilitating the electronic clearing and settlement of its shares in the United States...
New Earth Resources Announces Private Placement
Vancouver, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- NEW EARTH RESOURCES CORP. (CSE: EATH) ("New Earth" or the "Company") is pleased to announce that it will be conducting a non-brokered private placement (the “Offering”) under which it will raise aggregate gross proceeds of up to $500,000 through the issuance of up to 4,166,667 units (each, a “Unit”) at a price of $0.12 per Unit. Each Unit will consist of one Class A common share (each, a “Share”) and one Share purchase warrant (each, a “Warrant”, entitling the holder to purchase one Share at a price of $0.18 for five years from the date of issuance)...
FCHL Receives Nasdaq Deficiency Notice on May 26, 2026
SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- On May 26, 2026, Fitness Champs Holdings Limited (“Fitness Champs Holdings”, “FCHL” or the “Company”) (NASDAQ: FCHL), a distinguished aquatic sports education provider in Singapore, received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), because (i) the stockholders' equity of the Company of $598,490 as of December 31, 2025, as reported in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, was below the minimum stockholders' equity requirement of $2,500,000 and (ii) the Company did not, as of May 26, 2026, meet the alternatives standards of market value of listed securities or net income from continuing operations for compliance with Nasdaq Listing Rule 5550(b)(1). Based on the proceeds of funds from a financing completed in May 2026, the Company believes it is now in compliance with the stockholders' equity requirements of Nasdaq Listing Rule 5550(b)(1); however the final determination of compliance is subject to review and approval by Nasdaq...
Ferrari Films Issues Formal Rebuttal to Forbes Article Mischaracterizing Section 168(k) as "Worthless" for Film Investors
LOS ANGELES--(BUSINESS WIRE)-- #168rules--Ferrari Films founder, attorney, and producer Stacy Kemp Ferrari today issued a point-by-point rebuttal to a Forbes article asserting that Section 168(k) of the Internal Revenue Code is "worthless as a tax shelter to raise financing for films." Ferrari contends the article contains critical legal oversights that, if left unchallenged, could mislead investors and producers who may have entirely lawful and well-structured grounds to benefit from the statute. "This ar...
AISIX Solutions Inc. Provides Status Report of Annual Financial Statements and MD&A
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - AISIX Solutions Inc. (TSXV: AISX) ("AISIX" or the "Company") provides this bi-weekly default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). The Company previously announced on May 1, 2026 that the British Columbia Securities Commission had issued a management cease trade order ("MCTO") further to the Company's application to the applicable securities regulatory authorities in Canada on the basis that the Company's audited annual financial statements, management's discussion and analysis and the applicable CEO and CFO certificates for the financial year ended December 31, 2025 (collectively, the "Annual Filings") would not be filed by the applicable filing deadline of April 30, 2026 (the "Default Announcement")...
Gold Basin Resources Provides Updates on Arrangement with CANEX
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Gold Basin Resources Corporation ("Gold Basin") (TSXV:GXX) announces updates with respect to the previously announced proposed arrangement (the "Arrangement") with CANEX Metals Inc. ("CANEX"). Reference is made to the arrangement agreement between Gold Basin and CANEX, dated May 11, 2026 (the "Arrangement Agreement"), and the management information circular dated May 14, 2026 in connection with Gold Basin's special meeting (the "Meeting") of shareholders ("Gold Basin Shareholders") to be held on June 4, 2026 with respect to the Arrangement (the "Arrangement Circular")...
Acceleware Ltd. Reports First Quarter 2026 Financial and Operating Results
Calgary, Alberta--(Newsfile Corp. - May 29, 2026) - Acceleware Ltd. (TSXV: AXE) ("Acceleware" or the "Company"), today announced its financial and operating results for the three months ended March 31, 2026 (all figures are in Canadian dollars unless otherwise noted).
Gap Inc. Investigation Initiated: SueWallSt Investigates the Officers and Directors of Gap Inc. (GAP)
Gap Inc. reported 1% Q1 revenue growth to $3.5 billion, missing Wall Street estimates, while Old Navy comparable sales came in at just 1% versus the 3% analysts expected -- shares fell over 15% in a single session. NEW YORK, May 29, 2026 /PRNewswire/ -- Investors who held Gap Inc. (NYSE: GAP) shares lost more than 15% of their investment on May 28-29, 2026, after the company reported Q1 FY2026 revenue of $3.5 billion -- up 1% year-over-year and below analyst expectations...
New Zealand Energy Corp. Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - New Zealand Energy Corp. (TSXV: NZ) ("NZEC" or the "Company") reports that further to the Company's news releases dated May 1 and 14, 2026 regarding the issuance of a management cease trade order by the British Columbia Securities Commission in connection with the delay in filing its annual disclosure documents (collectively, the "Annual Filings") for the year ended December 31, 2025 (the "MCTO News Release"), the Company confirms that work on the required documents is continuing and progressing. The Company continues to work closely with its independent reserves evaluator and external auditors to complete the reserves evaluation process and finalize the audited annual consolidated financial statements as expeditiously as possible...
Delivra Health and Its Brands Dream Water(R) and LivRelief(TM) Report Results for Third Quarter of Fiscal 2026
Third quarter sales reflect the impact of the continued changes in the global geopolitical landscape that has temporarily impacted outbound shipments from the USA to the Middle East distribution partners Third quarter sales and year-to-date sales growth of Dream Water Canada E-commerce of 16% and 13% respectively offset by a decline in Dream Water Canada Retail of 15% and 6% respectively compared to same periods last year Third quarter sales and year-to-date sales growth of LivRelief™ E-commerce of 60% and 32% respectively offset by a decline in LivRelief™ Retail of 30% and 27% respectively compared to same periods last year Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the three and nine months ended March 31, 2026. The Delivra Health portfolio features innovative brands Dream Water and LivRelief™, which deliver relief from common health issues such as sleeplessness, chronic pain and anxiety...
Clean Energy Technologies Receives Notice of Deficiency from Nasdaq
IRVINE, CA, May 29, 2026 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy technology and solutions provider focused on converting waste and heat into power and fuels, announces that on May 26, 2026, it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Quarterly Report”)...
ThreeD Capital Inc. Releases Results For the Three and Nine Months Ended March 31, 2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce its unaudited results as at and for the three and nine months ended March 31, 2026...
K92 Mining Announces Voting Results of Annual General Meeting of Shareholders
VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce the voting results of its 2026 annual general meeting (“AGM”) of shareholders that was held today as a hybrid virtual and in-person event. All of the resolutions proposed at the AGM were duly passed...
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
Together the allowances deepen protection across two priority franchises and reinforce a patent estate of approximately 250 issued and pending patents and patent applications worldwide NEW YORK, May 29, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Canadian Intellectual Property Office (CIPO) has issued Notices of Allowance for two patent applications spanning the Company's Actimab-A and Iomab-ACT programs. The allowances broaden Actinium's intellectual property protection across both hematologic malignancies and next-generation conditioning for gene-edited cell-based therapies in Canada, an important market within the Company's growing global patent estate...
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice
NEW YORK, May 29, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced it will provide a program update on its first-in-class Actinium-225 (225Ac) antibody radioconjugate, ATNM-400, highlighting new data that will be showcased across three presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting, taking place May 30-June 2, 2026, in Los Angeles, California. Two of the presentations showcase ATNM-400's differentiated profile across prostate cancer and non-small cell lung cancer (NSCLC), while a third demonstrates the importance of radioconjugate optimization for radiotherapies in the context of the Company's pipeline candidates...
Republic Technologies Inc. Provides Bi-Weekly Update On Annual Filings
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $DOCKF #Blockchain--Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (OTCQB: DOCKF) (“Republic” or the "Company") today provided an update with respect to its previously announced management cease trade order ("MCTO") in connection with the Company's filing of its audited annual financial statements (the " Financial Statements") and management discussion and analysis (the "MD&A") for the financial year ended December 31, 2025, and the applicable CEO and CFO certi...
Hydro One seeks approval from the Ontario Energy Board to build the Orléans Area Reinforcement Project
This investment will support economic growth in the Ottawa area TORONTO, May 29, 2026 /PRNewswire/ - Today, Hydro One Networks Inc. (Hydro One) announced it has filed a leave-to-construct application with the Ontario Energy Board (OEB) to seek approval to build the Orléans Area Reinforcement Project. The Orléans Area Reinforcement Project includes the construction of a new 11-kilometre 115-kilovolt (kV) transmission line within an existing transmission corridor between Hawthorne Transformer Station (TS) and Orléans TS, located in the Greater Ottawa Area...
$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors
PHOENIX--(BUSINESS WIRE)---- $mmi #apartmentinvestments--$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors.
Sable Offshore Corp. to Host Conference Call on June 1, 2026
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. to Host Conference Call on June 1, 2026.
Celularity Receives Nasdaq Notice Regarding Form 10-Q
FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it received a notification letter on May 27, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that, as a result of the Company's delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission...
Galloper Gold Closes Fully Funded $2.2M Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Galloper Gold Corp. (CSE: BOOM) (OTC Pink: GGDCF) (the "Company" or "Galloper") is pleased to announce that, further to its news release of May 22, 2026, it has closed its non-brokered private placement (the "Private Placement") raising $2,226,996 in gross proceeds through the issuance of (i) 16,891,633 flow-through common shares (each a "FT Share") at $0.12 per FT Share for gross proceeds of $2,026,996, and (ii) 2,000,000 common shares (each a "Share") at $0.10 per Share for gross proceeds of $200,000. The Company paid finder's fees totalling $71,890 in cash to BMO Nesbitt Burns Inc., Canaccord Genuity Corp. and Ventum Financial Corp. in accordance with applicable securities laws and the policies of the Canadian Securities Exchange...
Vitalist Announces Change of Auditor
CALGARY, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSX-V: VITA.V ; OTCQB: VTLSF) ("Vitalist", "we", "our" or the "Company"), a dynamic global smartwatch company, today announced a planned transition of its independent auditor. Following a recommendation from the Audit Committee, the Board of Directors has appointed Davidson & Company LLP as the Company's auditor, effective May 21, 2026...
SABA Announces Notification of Sources of Distributions
NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of th...
BRW Announces Notification of Sources of Distributions
NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the In...
Pine Cliff Energy Ltd. Announces Results of Shareholders' Meeting, Annual Share Unit and Stock Option Grant, and Declares Monthly Dividend for June 30, 2026
Calgary, Alberta--(Newsfile Corp. - May 29, 2026) - Pine Cliff Energy Ltd. (TSX: PNE) (OTCQX: PIFYF) ("Pine Cliff" or the "Company") is pleased to announce all matters presented for approval at the Annual Meeting of Shareholders on May 29, 2026 (the "Meeting") have been approved.
Aether Catalyst Solutions, Inc. Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Burnaby, British Columbia--(Newsfile Corp. - May 29, 2026) - Aether Catalyst Solutions, Inc. (CSE: ATHR) (FSE: 2QZ) (OTCQB: ATHHF) ("ATHR" or the "Company") announces that it is relying on the exemptions provided under Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order") and move to semi-annual financial reporting ("SAR"). The Blanket Order allows eligible venture issuers to voluntarily move from quarterly to semi-annual financial reporting...
FingerMotion Reports FY 2026 Financial Results
Singapore, Singapore--(Newsfile Corp. - May 29, 2026) - FingerMotion Inc. (NASDAQ: FNGR) ("FingerMotion" or the "Company"), a mobile services, data and technology company, is pleased to report its financial results for the year ended February 28, 2026. To review the full financial results, please view the Company's recent 10-K filing at www.sec.gov/edgar/search, which should be read in connection with this news release...
NEUBERGER REAL ESTATE SECURITIES INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger Real Estate Securities Income Fund Inc. (NYSE American: NRO) (the "Fund") has announced a distribution declaration of $0.0312 per share of common stock. The distribution announced today is payable on June 30, 2026, has a record date of June 15, 2026, and has an ex-date of June 15, 2026...
NEUBERGER NEXT GENERATION CONNECTIVITY FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger Next Generation Connectivity Fund Inc. (NYSE: NBXG) (the "Fund") has announced a distribution declaration of $0.12 per share of common stock. The distribution announced today is payable on June 30, 2026, has a record date of June 15, 2026, and has an ex-date of June 15, 2026...
Kane Biotech Announces Grant of Stock Options
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that on May 28, 2026 it granted an aggregate of 9,750,000 stock options (the "Options") to certain directors, officers, employees and consultants of the Company in accordance with the Company's third amended and restated stock option plan. Each Option is exercisable into one common share of the Company (a “Share”) at a price of $0.05 per Share, for a period of five years from the date of grant...
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29, 2026, has a record date of June 15, 2026, and has an ex-date of June 15, 2026...
Theralase(R) Releases Q1 2026 Financial Statements
Theralase(R) Provides an Update on its Phase II Bladder Cancer Clinical Study Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's unaudited interim consolidated financial statements for the three-month period ended March 31st, 2026 ("Financial Statements"). Theralase will be hosting a conference call on June 9 th at 11:00 am ET, which will include a presentation of the financial and operational results for the quarter ended March 31st, 2026...
Desert Gold Ventures Inc. Announces the Adoption of Semi-Annual Reporting
Surrey, British Columbia--(Newsfile Corp. - May 29, 2026) - Desert Gold Ventures Inc. (TSXV: DAU) (the "Company") elects to adopt the policies outlined in the semi-annual reporting ("SAR") pilot program utilizing the exemptions provided under Coordinated Blanket Order 51-933, Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order"). The SAR pilot program is implemented under the Blanket Order, which allows eligible venture issuers listed on the TSX Venture Exchange or the Canadian Securities Exchange to voluntarily move from quarterly to semi-annual financial reporting...
Fairfax Completes Sale of Portion of its Interest in Poseidon Corp.
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announced today that it, together with certain of its affiliates (collectively, “Fairfax”), has completed the previously announced sale of an aggregate of 67,618,981 common shares (the “Shares”) of Poseidon Corp. (“Poseidon”), the holding company that owns Seaspan Corporation, at a price of US$28.30 per share, for aggregate proceeds of approximately US$1.91 billion and a pre-tax realized gain of approximately US$837 million...
JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
BOSTON, May 29, 2026 /PRNewswire/ - John Hancock Premium Dividend Fund (NYSE: PDT) (the "Fund"), a closed-end fund managed by John Hancock Investment Management LLC and subadvised by Manulife Investment Management (US) LLC, announced today sources of its monthly distribution of $0.0825 per share paid to all shareholders of record as of May 11, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission...
Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2026, Management's Discussion and Analysis and related filings on SEDAR+ (www.sedarplus.ca). The Company reported net income of $5.0 million, total liabilities of $1.3 million and total assets of $27.8 million, including a 26.6% equity interest in a Korean private company called OQPBIOM that was valued at $19.8 million as at January 31, 2026...
YieldMax® ETFs Announces Planned Closure of Four ETFs
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- YieldMax ETFs today announced the planned closure and liquidation of four exchange-traded funds: YieldMax ABNB Option Income Strategy ETF (NYSE: ABNY) YieldMax DIS Option Income Strategy ETF (NYSE: DISO) YieldMax Dorsey Wright Featured 5 Income ETF (Nasdaq: FEAT) YieldMax Dorsey Wright Hybrid 5 Income ETF (Nasdaq: FIVY) Portfolio Review and Rationale YieldMax regularly reviews its ETFs and evaluates each fund's role within the broader YieldMax suite of ETFs, assessing investor demand, market dynamics, and the best use of its resources. Following this review, YieldMax has determined to close these four funds...
Patagonia Gold Quarter 1 2026 Financial Results
VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its financial results for the quarter ended March 31, 2026 (“Q1 2026”). The financial statements together with the related management's discussion and analysis are available on the Company's website and under the Company's profile on SEDAR+ at www.sedarplus.ca...
PBF Energy to Participate in Bank of America Energy and Power Credit Conference
PARSIPPANY, N.J., May 29, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Bank of America Energy and Power Credit Conference on June 3, 2026.
Playgon Announces Strategic Repositioning and Upcoming Annual and Special Meeting of Shareholders, Proposed Share Consolidation, Name Change, Settlement of Outstanding Debt and up to $10 Million Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Playgon Games Inc. (TSXV: DEAL) (OTC Pink: PLGNF) (FSE: 7CR) ("Playgon" or the "Company"), a propriety SaaS technology company delivering mobile live dealer technology to online gaming operators globally, is pleased to announce that it will hold its next annual and special meeting (the "Meeting") of its shareholders (the "Shareholders") on June 29, 2026 for purposes of, among other things, approving a share consolidation (the "Share Consolidation") and a settlement of outstanding debt in consideration for the issuance of common shares ("Common Shares") of the Company (the "Debt Settlement"). In connection with the Meeting, a management information circular of the Company (the "Circular") will be filed and mailed to the Shareholders of record as at the applicable record date on or about May 29, 2026, and will be available under the Company's SEDAR+ profile available for viewing at www.sedarplus.ca...
IBC Advanced Alloys Reports Improved Financial Results for the Quarter Ended March 2026
Highlights (Unless otherwise noted, all financial amounts in this news release are expressed in U.S. dollars. IBC is reporting the performance of "continuing operations" at its Copper Alloy division, "discontinued operations" at its Massachusetts facility, and a combination of continuing and discontinued operations.1 Fiscal year-to-date (YTD) sales of $13.8 million increased by 6.4% over the comparable prior-year period, driven primarily by sharply higher naval defense sector demand...
Great Pacific Gold Announces Departure of VP Corporate Development
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: GPGCF) (FSE: 0B3) ("Great Pacific Gold," "GPAC," or the "Company") announces that Mick Carew, Vice President of Corporate Development, has resigned from the Company effective immediately following his election to the Board of Directors of K92 Mining Inc at their Annual General Meeting earlier today. "We would like to congratulate Mick on his appointment to the board of K92 and thank him for all his hard work at Great Pacific Gold...
NEUBERGER ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger Energy Infrastructure and Income Fund Inc. (NYSE American: NML) (the "Fund") has announced a distribution declaration of $0.07008 per share of common stock. The distribution announced today is payable on June 30, 2026, has a record date of June 15, 2026, and has an ex-date of June 15, 2026...
Amendment: Fab-Form Industries Ltd. Announces Results for the Quarter Ended 31 March 2026
Delta, British Columbia--(Newsfile Corp. - May 29, 2026) - Fab-Form Industries Ltd. (TSXV: FBF) ("Fab-Form" or the "Company") announces a correction to press release on its interim financial results for the quarter ended 31 March 2026.
Stardust Solar Closes First Tranche of Non-Brokered Private Placement and Announces Downsizing of Offering
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Stardust Solar Energy Inc. (TSXV: SUN) (OTCQB: SUNXF) (FSE: 6330) ("Stardust Solar" or the "Company"), a globally expanding renewable energy company, announces, further to its news release of May 13, 2026, that it has completed the first tranche (the "First Tranche") of its previously announced non-brokered private placement of units (the "Offering"). As well, in a response to its investor's desires, the Company announces that it has downsized the aggregate maximum size of the Offering from $3,000,000 (as previously announced) to $1,500,000...
Safe Bulkers, Inc. Announces Availability of 2025 Sustainability Report
MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's 2025 Sustainability Report is available for download and can be accessed from its website using the link provided below...
Cloudastructure Receives Notice From Nasdaq
PALO ALTO, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI), a provider of AI-powered video surveillance, remote monitoring, and cloud-based security analytics, today announced it received a notice from Nasdaq on May 26, 2026 indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission...
Sego Announces Flow Through Financing
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Sego Resources Inc.(TSXV: SGZ) ("Sego" or "the Company"), is pleased to announce a critical minerals flow through financing. The gross proceeds of the financing will be used for exploration at the Miner Mountain project, located near Princeton, BC...
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Company Announcement COPENHAGEN, Denmark; May 29, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons...
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented new overall survival data from its pivotal Phase 3 ROSELLA trial of Lifyorli™ (relacorilant) plus nab-paclitaxel (a taxane chemotherapy) in an oral presentation at the ASCO 2026 (Ame...
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla...
State Street to Speak at the Morgan Stanley U.S. Financials Conference
BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) announced today that its Chief Financial Officer, John Woods, will present at the Morgan Stanley U.S. Financials Conference in New York, NY on Wednesday, June 10, 2026 at approximately 1:45 pm ET. An audio webcast of the event will be accessible on the home page of State Street's Investor Relations website, https://investors.statestreet.com/. A recorded replay will be available on the Investor Relations website later that day, for ap...
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 2,991,840 shares of its class A common stock in the aggregate to 33 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee's commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to Nasdaq Listing Rule 5635(c)(4)...
KB HOME OPENS ASHFORD WITHIN PLACER ONE, A SOUGHT-AFTER MASTER PLAN IN HIGHLY DESIRABLE ROSEVILLE, CALIFORNIA
New community with planned amenities and close to highly ranked schools is now open for tours. ROSEVILLE, Calif.
Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Quarterly Report
SHOUGUANG, China, May 29, 2026 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources,” “we,” or the “Company”), a leading manufacturer of bromine and crude salt in China, today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualification Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) on May 26, 2026 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its quarterly report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission...
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced that the Company has granted options to purchase an aggregate of 33,000 shares of the Company's common stock (the “Inducement Awards”) to four new employees pursuant to the Company's 2023 Employment Inducement Award Plan. Each Inducement Award vests over four years, with 25% vesting on the first anniversary of the employee's start date, and the remainder vesting in three equal annual installments thereafter (subject to each such employee's continued employment on each vesting date)...
Defiance ETFs Announces Closure of BU and CVNX Funds
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate two exchange-traded funds: the Defiance Daily Target 2X Long B ETF (Nasdaq: BU), and the Defiance Daily Target 2X Long CVNA ETF (Nasdaq: CVNX). The final day of trading for BU and CVNX (the “funds”) on the Nasdaq will be Monday, June 8, 2026...
Freddie Mac Issues Monthly Volume Summary for April 2026
MCLEAN, Va., May 29, 2026 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for April 2026, which provides information on Freddie Mac's mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments...
Principal Real Estate Income Fund Announces Notification of Sources of Distribution
DENVER--(BUSINESS WIRE)--The Principal Real Estate Income Fund (NYSE:PGZ) announces the sources of a distribution paid on May 29, 2026 of $0.1050 per share to shareholders of record at the close of business on May 14, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission and includes the notice below sent to shareholders regarding the source of the distribution. St...
Fortegra Completes Acquisition by DB Insurance
JACKSONVILLE, Fla.--(BUSINESS WIRE)--The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline...
Ionik Reports Q1 2026 Revenue Growth and Continued Debt Reduction
Revenue increased 11% year-over-year to $44.3 million Total debt reduced by $5.3 million (All figures in US dollars, unless otherwise indicated) Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - Ionik Corporation (TSXV: INIK) (OTCQB: INIKF) (the "Company" or "Ionik"), a data and technology-driven marketing platform, today announced financial results for the three months ended March 31, 2026, highlighting continued revenue growth across both operating divisions, continued debt reduction, and further progress on platform integration. Q1 2026 Financial Highlights Revenue of $44.3 million, up 11% from $39.9 million in the same period of the prior year ("Q1 2025"), driven by growth in both the Media Activation and Marketing Optimization divisions...
SATO Technologies Corp. Reports First Quarter 2026 Results
Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - SATO Technologies Corp. (TSXV: SATO) (OTCQB: CCPUF) ("SATO" or the "Company") today announced its unaudited financial results for the three months ended March 31, 2026. Unaudited condensed interim consolidated financial statements and MD&A are filed on SEDAR+ (www.sedarplus.ca) and available at www.bysato.com...
Ares Management Corporation to Present at the Morgan Stanley US Financials Conference
NEW YORK, NY / ACCESS Newswire / May 29, 2026 / Ares Management Corporation announced today that its Co-Founder and Chief Executive Officer, Michael Arougheti, is scheduled to present at the Morgan Stanley US Financials Conference on Wednesday, June 10, 2026, at 12:05pm ET. A live audio webcast of the presentation will be available on the Investor Resources section of the Company's website at www.ares.com...